These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30150480)

  • 1. Attributable Cost and Length of Stay Associated with Nosocomial Gram-Negative Bacterial Cultures.
    Nelson RE; Stevens VW; Jones M; Khader K; Schweizer ML; Perencevich EN; Rubin MA; Samore MH
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of hospital length of stay on the distribution of Gram negative bacteria and likelihood of isolating a resistant organism in a Canadian burn center.
    Wanis M; Walker SAN; Daneman N; Elligsen M; Palmay L; Simor A; Cartotto R
    Burns; 2016 Feb; 42(1):104-111. PubMed ID: 26547832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients.
    Warren DK; Hill HA; Merz LR; Kollef MH; Hayden MK; Fraser VJ; Fridkin SK
    Crit Care Med; 2004 Dec; 32(12):2450-6. PubMed ID: 15599150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare-Associated Infections Due to Multidrug-Resistant Organisms: a Surveillance Study on Extra Hospital Stay and Direct Costs.
    Giraldi G; Montesano M; Napoli C; Frati P; La Russa R; Santurro A; Scopetti M; Orsi GB
    Curr Pharm Biotechnol; 2019; 20(8):643-652. PubMed ID: 30961489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria.
    Mauldin PD; Salgado CD; Hansen IS; Durup DT; Bosso JA
    Antimicrob Agents Chemother; 2010 Jan; 54(1):109-15. PubMed ID: 19841152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and economic burden of antimicrobial resistance.
    Maragakis LL; Perencevich EN; Cosgrove SE
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):751-63. PubMed ID: 18847410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
    Lima EM; Cid PA; Beck DS; Pinheiro LHZ; Tonhá JPS; Alves MZO; Lourenço ND; Santos RQ; Asensi MD; Marques JA; Bandeira CS; Rodrigues CAS; Gomes Junior SCS; Gomes MZR;
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):132. PubMed ID: 32795380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections.
    Thaden JT; Li Y; Ruffin F; Maskarinec SA; Hill-Rorie JM; Wanda LC; Reed SD; Fowler VG
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High excess costs of infections caused by carbapenem-resistant Gram-negative bacilli in an endemic region.
    Vargas-Alzate CA; Higuita-Gutiérrez LF; López-López L; Cienfuegos-Gallet AV; Jiménez Quiceno JN
    Int J Antimicrob Agents; 2018 Apr; 51(4):601-607. PubMed ID: 29277527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of multidrug resistance in healthcare-associated and nosocomial Gram-negative bacteraemia on mortality and length of stay: cohort study.
    Lye DC; Earnest A; Ling ML; Lee TE; Yong HC; Fisher DA; Krishnan P; Hsu LY
    Clin Microbiol Infect; 2012 May; 18(5):502-8. PubMed ID: 21851482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The excess financial burden of multidrug resistance in severe gram-negative infections in Singaporean hospitals.
    Ng E; Earnest A; Lye DC; Ling ML; Ding Y; Hsu LY
    Ann Acad Med Singap; 2012 May; 41(5):189-93. PubMed ID: 22760715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of serious infections due to Gram-negative bacteria on the hospital economy].
    Martínez B; Gómez J; Gómez Vargas J; Guerra B; Ruiz Gómez J; Simarro E; Baños V; Canteras M; Valdes M
    Rev Esp Quimioter; 2000 Dec; 13(4):374-8. PubMed ID: 11498703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gram-negative antibiotic resistance: there is a price to pay.
    Slama TG
    Crit Care; 2008; 12 Suppl 4(Suppl 4):S4. PubMed ID: 18495061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit.
    Blot S; Depuydt P; Vogelaers D; Decruyenaere J; De Waele J; Hoste E; Peleman R; Claeys G; Verschraegen G; Colardyn F; Vandewoude K
    Infect Control Hosp Epidemiol; 2005 Jun; 26(6):575-9. PubMed ID: 16018434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
    Ting SW; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of nosocomial pneumonia in infants after cardiac surgery.
    Tan L; Sun X; Zhu X; Zhang Z; Li J; Shu Q
    Chest; 2004 Feb; 125(2):410-7. PubMed ID: 14769717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collateral benefit of screening patients for methicillin-resistant Staphylococcus aureus at hospital admission: isolation of patients with multidrug-resistant gram-negative bacteria.
    Jones M; Nielson C; Gupta K; Khader K; Evans M
    Am J Infect Control; 2015 Jan; 43(1):31-4. PubMed ID: 25442394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections.
    Bonine NG; Berger A; Altincatal A; Wang R; Bhagnani T; Gillard P; Lodise T
    Am J Med Sci; 2019 Feb; 357(2):103-110. PubMed ID: 30665490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of factors influencing the risk of secondary infection in patients colonized or infected with multidrug-resistant Gram-negative bacteria following hospitalization.
    Xu M; Zeng J
    Microb Pathog; 2024 May; 190():106637. PubMed ID: 38570103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.